PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 56 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

24 November 2024

  1. (diff | hist) 05:51 Repackaging 2,904 ±0 ResinRhoswen (talk | contribs) expand §Why the record is the whole thing [rollback]
  2. (diff | hist) m b 04:35 Preparative HPLC purification 3,390 +29 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  3. (diff | hist) m 03:32 Lixisenatide 2,302 +255 LotTraceLuka (talk | contribs) state which salt form the mass in the infobox refers to [rollback]

23 November 2024

  1. (diff | hist) 21:10 Cold-chain freight 2,385 +271 MelanocortinMil (talk | contribs) add the customs-detention point as a logistics fact, sourced [rollback]
  2. (diff | hist) m 19:34 GL Biochem (Shanghai) 8,543 +883 FiveOhThreeA (talk | contribs) expand §Operations and documentation practice [rollback]
  3. (diff | hist) m 13:14 Mass spectrometry 4,018 +137 ColumnOvenCoy (talk | contribs) ce, tighten prose [rollback]
  4. (diff | hist) 10:41 Weight regain after discontinuation 2,939 +117 ITT_Imelda (talk | contribs) add the rebound point with the follow-up study it comes from [rollback]
  5. (diff | hist) m 09:54 Albumin binding half-life extension 3,310 +153 NavboxNiko (talk | contribs) add the counter-regulatory glucagon point, sourced [rollback]
  6. (diff | hist) 05:44 TRIUMPH trial programme 2,837 ±0 ForestPlotFinn (talk | contribs) split overlong sentence [rollback]
  7. (diff | hist) m 05:02 Drug master file 2,196 +407 HarmReductionHen (talk | contribs) clarify that a business licence is not a manufacturing authorisation [rollback]

22 November 2024

  1. (diff | hist) 23:49 Loss on drying 2,569 ±0 LeanMassLars (talk | contribs) convert the method-comparison paragraph to a table [rollback]
  2. (diff | hist) m b 15:20 Subcutaneous injection 3,690 +704 StubSorterBot (talk | contribs) bot: repair redlinked category [rollback]
  3. (diff | hist) 13:09 Melanotan II 1,177 ±0 Hedgerow_Hal (talk | contribs) split overlong sentence [rollback]
  4. (diff | hist) m 10:24 Orforglipron 1,574 ±0 SemaglutideSasha (talk | contribs) British spelling per PP:MOS [rollback]
  5. (diff | hist) 10:07 Talk:Beyond-use date 1,170 +181 FiveOhThreeA (talk | contribs) /* The 25% rule keeps being reinstated */ reply
  6. (diff | hist) 10:03 Talk:Shanghai Sigma-Audley New Material Technology 822 +211 Hedgerow_Hal (talk | contribs) /* Notability and the registered business scope */ reply
  7. (diff | hist) N 09:00 Sarcopenia 1,173 +1,173 ApoB_Aurelio (talk | contribs) new article: laboratory medicine, expansion welcome
  8. (diff | hist) 06:02 STEP trial programme 4,022 +113 DrTitration (talk | contribs) space between number and unit per PP:MOS [rollback]
  9. (diff | hist) m b 03:59 Cagrilintide 2,938 +532 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  10. (diff | hist) 01:33 ChinaPeptides 3,950 +1,017 COA_Colwyn (talk | contribs) expand §Distribution and dispatch [rollback]

21 November 2024

  1. (diff | hist) 22:43 GLP-1 receptor 5,187 +119 SatietySunniva (talk | contribs) convert the receptor-distribution list to a table [rollback]
  2. (diff | hist) 20:40 Sterility testing 2,614 ±0 NewLabNell (talk | contribs) convert the method-comparison paragraph to a table [rollback]
  3. (diff | hist) m b 18:14 Customs seizure 1,799 ±0 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]
  4. (diff | hist) 12:15 Talk:Shanghai Sigma-Audley New Material Technology 611 +269 ScopeSeverin (talk | contribs) /* Notability and the registered business scope */ reply
  5. (diff | hist) 11:04 Talk:Tianjin Finder Chemical 1,033 +129 CDMO_Caradoc (talk | contribs) /* Manufacturer or distributor? */ reply
  6. (diff | hist) 10:34 ISO 9001 2,449 ±0 AnalyticalAnnie (talk | contribs) fix the anchor on an internal link [rollback]
  7. (diff | hist) m 10:14 C-peptide 2,537 ±0 LabRangeLindy (talk | contribs) fix indentation in the source [rollback]
  8. (diff | hist) 09:48 Talk:Shanghai Sigma-Audley New Material Technology 400 +409 NotabilityNoa (talk | contribs) /* Notability and the registered business scope */ new section
  9. (diff | hist) 09:35 Regulatory status by jurisdiction 2,139 ±0 GreyMarketGreer (talk | contribs) clarify that a business licence is not a manufacturing authorisation [rollback]
  10. (diff | hist) m 06:59 Trifluoroacetate counterion 2,739 ±0 LOD_Lorcan (talk | contribs) clarify the difference between related substances and total impurities [rollback]
  11. (diff | hist) 04:10 Liraglutide 3,273 ±0 CuriousCallum (talk | contribs) the half-life in the lead was the terminal figure; label it as such [rollback]
  12. (diff | hist) 01:47 Retatrutide 4,481 +404 AppendixAlva (talk | contribs) rm the equipotency claim — the cited paper does not make it [rollback]
  13. (diff | hist) m 01:03 Deamidation 2,307 +287 Retention_Time_Rae (talk | contribs) correct the water-content figure — the source reports it on a dry basis [rollback]

20 November 2024

  1. (diff | hist) 21:18 Enteroendocrine L cell 3,351 ±0 GlossaryGleb (talk | contribs) the article treated a rodent finding as human physiology; corrected [rollback]
  2. (diff | hist) 20:43 Vial filling and stoppering 2,480 +465 FmocFrancis (talk | contribs) add the figure for the lyophilisation cycle and caption it [rollback]
  3. (diff | hist) 20:24 Underfilling 1,727 +619 Ref_Desk_Ron (talk | contribs) clarify that a QR code on a certificate proves issuance, not content [rollback]
  4. (diff | hist) 16:16 Peptide content 3,952 +429 NauseaNoor (talk | contribs) add category for method validation [rollback]
  5. (diff | hist) 15:31 Cold chain 15,523 +1,581 eGFR_Esme (talk | contribs) add the crimp-seal step to the fill-and-finish description [rollback]
  6. (diff | hist) m b 15:07 Purity claim inflation 2,670 +432 StubSorterBot (talk | contribs) bot: normalise citation format [rollback]
  7. (diff | hist) 13:37 Bacterial endotoxin test 2,929 ±0 KarlFischerKit (talk | contribs) add the forced-degradation conditions the claim rests on [rollback]
  8. (diff | hist) 11:56 Survodutide 2,514 +1,058 IcodecIndra (talk | contribs) state the substitution in one-letter code as well, per PP:MOS [rollback]
  9. (diff | hist) N 09:00 Orforglipron 1,574 +1,574 SemaglutideSasha (talk | contribs) new article: compound, expansion welcome
  10. (diff | hist) 08:52 Talk:Beyond-use date 959 +161 CitationChaser (talk | contribs) /* The 25% rule keeps being reinstated */ reply
  11. (diff | hist) 08:12 Insulin syringe unit conversion 1,989 +494 OpenLabelOtto (talk | contribs) add the caveat that concentration and dose are not the same quantity [rollback]
  12. (diff | hist) 05:30 Customs seizure 1,799 +747 Compounding_Cate (talk | contribs) correct the description of the shortage-list mechanism [rollback]
  13. (diff | hist) 04:40 WuXi TIDES 7,111 +1,195 SecondarySrc_Seb (talk | contribs) add the incorporation year, attributed to the registry record [rollback]
  14. (diff | hist) m b 03:14 GLP-1 receptor agonist 8,122 +1,583 CiteBot (talk | contribs) bot: expand DOI to full citation [rollback]
  15. (diff | hist) m 00:41 Contract development and manufacturing organisation 2,252 ±0 SupplyWatchSuri (talk | contribs) add the reconstitution-stability sentence with its storage condition [rollback]

19 November 2024

  1. (diff | hist) 23:52 Liquid chromatography-mass spectrometry 2,642 ±0 ForgeryFinder (talk | contribs) space between number and unit per PP:MOS [rollback]
  2. (diff | hist) 20:07 Medutest 2,738 ±0 GroupBuyGalen (talk | contribs) add the note that self-submitted reports are a self-selected sample [rollback]
  3. (diff | hist) 19:41 Haemoglobin A1c 2,610 +36 DrTitration (talk | contribs) de-orphan [rollback]
  4. (diff | hist) 16:23 Baseline laboratory panel 2,304 +357 BaselineBex (talk | contribs) expand §Common components [rollback]
  5. (diff | hist) 14:45 Placebo-adjusted effect 2,853 +696 TriumphThad (talk | contribs) fix a dangling clause [rollback]
  6. (diff | hist) 12:15 Talk:Beyond-use date 748 +323 Compounding_Cate (talk | contribs) /* The 25% rule keeps being reinstated */ reply
  7. (diff | hist) 09:53 Reverse-phase HPLC 3,742 +697 TechnicianTeal (talk | contribs) correct the resolution formula — the denominator is the sum of the widths [rollback]
  8. (diff | hist) 09:38 Talk:Beyond-use date 537 +332 FiveOhThreeA (talk | contribs) /* The 25% rule keeps being reinstated */ new section
  9. (diff | hist) 09:37 Talk:Tianjin Finder Chemical 822 +169 RepackRadek (talk | contribs) /* Manufacturer or distributor? */ reply
  10. (diff | hist) 09:33 Insulin secretion 4,409 +469 LCellLeif (talk | contribs) expand §The triggering pathway [rollback]
  11. (diff | hist) N 09:00 Melanotan II 1,177 +1,177 ITT_Imelda (talk | contribs) start article; sequence and sourcing only so far
  12. (diff | hist) m 06:34 Contraindications of incretin therapy 2,065 ±0 NAION_Noel (talk | contribs) add the rebound point with the follow-up study it comes from [rollback]
  13. (diff | hist) 04:14 USP General Chapter 85 2,668 +582 OffLabelOdile (talk | contribs) British spelling per PP:MOS [rollback]
  14. (diff | hist) m 04:08 Underfilling 1,108 ±0 Chromatokid (talk | contribs) add the note that a purity figure without water and counterion is not a mass [rollback]
  15. (diff | hist) m 03:58 Qingdao Sigma Chemical 5,662 +386 SharpsSukhi (talk | contribs) add the see-also to the certificate-of-analysis article [rollback]
  16. (diff | hist) 00:43 Triple agonist 2,546 ±0 EndpointEnid (talk | contribs) rm the equipotency claim — the cited paper does not make it [rollback]
  17. (diff | hist) 00:27 Resin cleavage 2,920 +557 ColdChainCleo (talk | contribs) correct the eutectic temperature — source gives a range [rollback]

18 November 2024

  1. (diff | hist) 21:53 Vial 12,879 +1,702 RepackRadek (talk | contribs) add the collapse-temperature point, sourced [rollback]
  2. (diff | hist) 14:26 Talk:Tianjin Finder Chemical 611 +290 Hedgerow_Hal (talk | contribs) /* Manufacturer or distributor? */ reply
  3. (diff | hist) 14:23 Guangzhou JEEP Biotechnology 7,655 +477 LedgerLysander (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  4. (diff | hist) m 14:11 International nonproprietary name 2,063 +230 SeeAlsoSelma (talk | contribs) attribute the mechanism claim to the review rather than stating it flatly [rollback]
  5. (diff | hist) 14:04 Blind sampling 3,727 +33 EndotoxinEd (talk | contribs) convert a hard-coded date to the house format [rollback]
  6. (diff | hist) 12:42 Tianjin Finder Chemical 3,070 +343 GroupBuyGalen (talk | contribs) add the outbound storefront link, marked nofollow and sponsored per the external-links convention [rollback]
  7. (diff | hist) m 11:24 Peptide supply chain 3,539 ±0 CDMO_Caradoc (talk | contribs) add the data-logger point: an unlogged shipment has no excursion record [rollback]
  8. (diff | hist) 10:52 Talk:Tianjin Finder Chemical 400 +283 CDMO_Caradoc (talk | contribs) /* Manufacturer or distributor? */ new section
  9. (diff | hist) 09:36 Peptide synthesis 3,621 +583 ColdChainCleo (talk | contribs) rm the vendor-specific packaging detail; not general enough for the article [rollback]
  10. (diff | hist) 09:06 Reference standard 3,644 +772 Areapercent_Ayo (talk | contribs) state the mass accuracy in parts per million rather than daltons [rollback]
  11. (diff | hist) N 09:00 Amino acid analysis 2,043 +2,043 LedgerLysander (talk | contribs) create article — method stub
  12. (diff | hist) m 03:29 Injection site rotation 2,929 ±0 GMP_Gita (talk | contribs) add the preservative point: unpreserved diluent changes the interval [rollback]
  13. (diff | hist) m 01:58 Amylin 3,238 +34 VerifyVesna (talk | contribs) the storage condition applies to the unopened pen; say so [rollback]
  14. (diff | hist) m 01:43 Methionine oxidation 2,072 +656 PuffRemoverPax (talk | contribs) add the figure for the chromatogram and caption its axes [rollback]

17 November 2024

  1. (diff | hist) m 23:17 Test report forgery 2,319 +321 BaselineBex (talk | contribs) expand §Internal signals [rollback]
  2. (diff | hist) m 11:11 Dual incretin agonist 3,465 +113 GroupBuyGalen (talk | contribs) move the trade-name history out of the lead and into §Regulatory history [rollback]
  3. (diff | hist) 09:42 Shanghai Sigma-Audley New Material Technology 2,703 +363 LotTraceLuka (talk | contribs) state what the certificate supplied with orders carries [rollback]
  4. (diff | hist) 08:32 Wuhan Wansheng Biotechnology 7,754 +308 ForgeryFinder (talk | contribs) rm the comparison with another supplier; there is no common basis for it [rollback]
  5. (diff | hist) 04:42 Intention-to-treat analysis 3,316 +625 TriumphThad (talk | contribs) add the trial acronym expansion at first use [rollback]
  6. (diff | hist) m b 01:30 Receptor bias 2,387 ±0 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  7. (diff | hist) 00:43 Glucagon-like peptide-1 8,227 +341 SatietySunniva (talk | contribs) fix hyphenation per PP:MOS [rollback]

16 November 2024

  1. (diff | hist) 22:20 Third-party testing 4,926 +481 EndpointEnid (talk | contribs) state the date range the submitted set covers [rollback]
  2. (diff | hist) m 21:47 Tirzepatide 5,120 +131 OralSemaOswin (talk | contribs) fix the anchor on an internal link [rollback]
  3. (diff | hist) 20:58 Bachem Holding (Suzhou) 4,631 +1,302 Chromatokid (talk | contribs) add the see-also to the certificate-of-analysis article [rollback]
  4. (diff | hist) 16:57 Missed dose 3,140 +30 DrTitration (talk | contribs) fix hyphenation per PP:MOS [rollback]
  5. (diff | hist) m 16:51 Aspiration risk under anaesthesia 2,646 +387 AnalyticalAnnie (talk | contribs) clarify that dose-dependence is reported for some effects and not others [rollback]
  6. (diff | hist) 16:33 Electrospray ionisation 2,601 +34 TrialsTabitha (talk | contribs) fix the anchor on an internal link [rollback]
  7. (diff | hist) 14:16 Dose escalation schedule 2,719 +500 CarryOverCai (talk | contribs) state that reconstituted material should not be frozen, with the source [rollback]
  8. (diff | hist) 13:01 Dulaglutide 3,106 ±0 ParentCatPansy (talk | contribs) rm duplicated pharmacokinetics — the same figures appear in the infobox [rollback]
  9. (diff | hist) m b 10:14 Lyophilisation 10,259 +907 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]
  10. (diff | hist) 07:50 Amylin receptor agonist 2,571 +35 ParentCatPansy (talk | contribs) label the animal data as animal data in the sentence, not only in the section heading [rollback]
  11. (diff | hist) 02:03 Lot traceability 2,794 ±0 Chromatokid (talk | contribs) fix the anchor on an internal link [rollback]

15 November 2024

  1. (diff | hist) 23:35 Semaglutide 6,658 +1,050 ColdChainCleo (talk | contribs) expand §Chemistry and engineering [rollback]
  2. (diff | hist) m 19:30 Solid-phase peptide synthesis 3,861 +484 PreregPriya (talk | contribs) expand §Difficult sequences [rollback]
  3. (diff | hist) 19:10 Beta cell function 3,162 ±0 MTC_Marisol (talk | contribs) distinguish the active and total forms of the hormone throughout [rollback]